差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 ALX Oncology Holdings Inc. - ALXO CFD

4.63
4.14%
0.05
低: 4.56
高: 4.84
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.05
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 4.83
開盤價* 4.78
1 年變化* -74.08%
日範圍* 4.56 - 4.84
52 周範圍 4.52-19.85
平均交易量（10 天） 447.44K
平均交易量（3 個月） 4.79M
市值 198.48M
市盈率 -100.00K
流通股 40.86M
收入 N/A
EPS -3.03
股息（收益率 %） N/A
貝塔 -100.00K
下一個財報發布日期 May 8, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 24, 2023 4.63 -0.13 -2.73% 4.76 4.84 4.54
Mar 23, 2023 4.83 0.29 6.39% 4.54 4.87 4.54
Mar 22, 2023 4.78 -0.04 -0.83% 4.82 4.95 4.63
Mar 21, 2023 4.79 0.09 1.91% 4.70 5.02 4.68
Mar 20, 2023 4.60 -0.16 -3.36% 4.76 4.78 4.49
Mar 17, 2023 4.76 -0.15 -3.05% 4.91 4.95 4.63
Mar 16, 2023 4.98 -0.08 -1.58% 5.06 5.13 4.92
Mar 15, 2023 5.17 0.09 1.77% 5.08 5.38 4.67
Mar 14, 2023 5.23 -0.49 -8.57% 5.72 5.74 5.07
Mar 13, 2023 5.60 0.42 8.11% 5.18 5.90 5.18
Mar 10, 2023 5.36 -0.33 -5.80% 5.69 5.73 5.02
Mar 9, 2023 5.84 -0.27 -4.42% 6.11 6.19 5.60
Mar 8, 2023 6.21 -0.16 -2.51% 6.37 6.39 6.11
Mar 7, 2023 6.37 0.07 1.11% 6.30 6.54 6.29
Mar 6, 2023 6.44 -0.04 -0.62% 6.48 6.48 6.20
Mar 3, 2023 6.50 0.19 3.01% 6.31 6.67 6.31
Mar 2, 2023 6.45 0.11 1.74% 6.34 6.47 6.23
Mar 1, 2023 6.48 0.04 0.62% 6.44 6.60 6.43
Feb 28, 2023 6.59 0.16 2.49% 6.43 6.66 6.43
Feb 27, 2023 6.63 0.15 2.31% 6.48 6.74 6.48

ALX Oncology Holdings Inc. Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018
總收入 0 1.182 4.796 2.067
收入 0 1.182 4.796 2.067
收入成本，共計 1.075 4.36 1.88
毛利 0.107 0.436 0.187
總營業費用 83.555 45.466 23.979 15.751
銷售/一般/行政費用，總計 23.385 14.809 3.313 2.601
研究與開發 60.17 28.961 16.306 11.27
營業收入 -83.555 -44.284 -19.183 -13.684
利息收入（費用），非經營淨值 -0.013 -0.811 -0.021 0
其他，淨值 0.084 -0.404 -0.005 -0.002
稅前淨收入 -83.484 -45.499 -19.209 -13.686
稅後淨收入 -83.463 -45.74 -19.243 -13.731
未計算非常項目前的淨收益 -83.463 -45.74 -19.243 -13.731
淨收入 -83.463 -45.74 -19.243 -13.731
Total Adjustments to Net Income 0 -5.202 -4.028 -3.671
普通股股東可獲收益 (不含非經常性項目) -83.463 -50.942 -23.271 -17.402
普通股股東可獲收益 (含非經常性項目) -83.463 -50.942 -23.271 -17.402
攤薄淨收入 -83.463 -50.942 -23.271 -17.402
攤薄後加權平均股 40.308 18.4853 34.7116 34.7116
扣除特別項目的每股攤薄盈利 -2.07063 -2.7558 -0.67041 -0.50133
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -2.07063 -2.73397 -0.67041 -0.50133
異常費用（收入） 0 0.621
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 0 0 0 0 0
收入 0 0 0 0
總營業費用 24.747 28.472 24.576 16.299 14.208
銷售/一般/行政費用，總計 7.674 7.578 6.362 5.086 4.359
研究與開發 17.073 20.894 18.214 11.213 9.849
營業收入 -24.747 -28.472 -24.576 -16.299 -14.208
利息收入（費用），非經營淨值 0.225 -0.003 -0.004 -0.003 -0.003
其他，淨值 -0.011 0.016 0.014 0.028 0.026
稅前淨收入 -24.533 -28.459 -24.566 -16.274 -14.185
稅後淨收入 -24.533 -28.438 -24.566 -16.274 -14.185
未計算非常項目前的淨收益 -24.533 -28.438 -24.566 -16.274 -14.185
淨收入 -24.533 -28.438 -24.566 -16.274 -14.185
Total Adjustments to Net Income 0 0 0 0
普通股股東可獲收益 (不含非經常性項目) -24.533 -28.438 -24.566 -16.274 -14.185
普通股股東可獲收益 (含非經常性項目) -24.533 -28.438 -24.566 -16.274 -14.185
攤薄淨收入 -24.533 -28.438 -24.566 -16.274 -14.185
攤薄後加權平均股 40.6163 40.5297 40.3962 40.2471 40.0554
扣除特別項目的每股攤薄盈利 -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.60402 -0.70166 -0.60813 -0.40435 -0.35413
收入成本，共計 0 0
毛利 0 0
異常費用（收入） 0
  • 年度
  • 每季度
2021 2020 2019 2018
流動資産總額 367.019 435.992 9.809 10.208
現金和短期投資 363.667 434.219 9.017 8.262
Cash 434.219 9.017 8.262
應收賬款總額，淨額 0 0.536 0.932
Accounts Receivable - Trade, Net 0 0.536 0.932
Prepaid Expenses 3.352 1.773 0.256 1.014
Total Assets 380.183 436.054 10.676 11.164
Property/Plant/Equipment, Total - Net 3.397 0.052 0.86 0.956
Property/Plant/Equipment, Total - Gross 3.46 0.077 2.309 1.976
Accumulated Depreciation, Total -0.063 -0.025 -1.449 -1.02
Other Long Term Assets, Total 9.767 0.01 0.007 0
Total Current Liabilities 15.295 6.204 4.984 1.873
Accounts Payable 3.764 0.004 3.748 0.697
Accrued Expenses 11.102 6.049 1.046 0.905
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 0.151 0.19 0.271
Total Liabilities 17.134 6.209 10.952 2.009
Total Long Term Debt 0.28 0 5.421 0
Long Term Debt 5.421 0
Other Liabilities, Total 1.559 0.005 0.547 0.136
Total Equity 363.049 429.845 -0.276 9.155
Preferred Stock - Non Redeemable, Net 70.363 60.933
Common Stock 0.041 0.04 0.021 0.021
Additional Paid-In Capital 564.993 548.327 2.122 1.74
Retained Earnings (Accumulated Deficit) -201.985 -118.522 -72.782 -53.539
Total Liabilities & Shareholders’ Equity 380.183 436.054 10.676 11.164
Total Common Shares Outstanding 40.5871 39.8445 34.7116 34.7116
Redeemable Preferred Stock 0
現金等價物 363.667
Current Port. of LT Debt/Capital Leases 0.429
Capital Lease Obligations 0.28
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 321.525 367.019 388.963 412.277 432.327
現金和短期投資 316.596 363.667 385.149 409.964 429.855
現金等價物 159.086 363.667 385.149 409.964 429.855
Prepaid Expenses 4.929 3.352 3.814 2.313 2.472
Total Assets 363.676 380.183 399.728 421.289 432.91
Property/Plant/Equipment, Total - Net 6.967 3.397 3.362 0.167 0.047
Property/Plant/Equipment, Total - Gross 7.088 3.46 3.401 0.2 0.077
Accumulated Depreciation, Total -0.121 -0.063 -0.039 -0.033 -0.03
Other Long Term Assets, Total 10.075 9.767 7.403 8.845 0.536
Total Current Liabilities 15.308 15.295 12.488 13.979 14.129
Accounts Payable 5.133 3.764 3.683 5.806 7.35
Accrued Expenses 9.746 11.102 8.376 7.744 2.735
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.429 0.429 0.429 0.429 0.095
Other Current Liabilities, Total 3.949
Total Liabilities 20.08 17.134 14.556 16.275 14.426
Total Long Term Debt 0.175 0.28 0.385 0.489 0.131
Capital Lease Obligations 0.175 0.28 0.385 0.489 0.131
Other Liabilities, Total 4.597 1.559 1.683 1.807 0.166
Total Equity 343.596 363.049 385.172 405.014 418.484
Redeemable Preferred Stock 0
Common Stock 0.041 0.041 0.04 0.04 0.04
Additional Paid-In Capital 570.679 564.993 558.679 553.955 551.151
Retained Earnings (Accumulated Deficit) -226.518 -201.985 -173.547 -148.981 -132.707
Total Liabilities & Shareholders’ Equity 363.676 380.183 399.728 421.289 432.91
Total Common Shares Outstanding 40.6566 40.5871 40.4863 40.3253 40.2086
短期投資 157.51
Long Term Investments 25.109
Other Equity, Total -0.606
  • 年度
  • 每季度
2021 2020 2019 2018
淨收入/起跑線 -83.463 -45.74 -19.243 -13.731
經營活動産生的現金 -68.101 -38.289 -14.249 -13.19
經營活動産生的現金 0.051 0.202 0.429 0.431
非現金物品 19.338 7.002 0.308 0.269
營運資金的變化 -4.027 0.247 4.257 -0.159
投資活動産生的現金 -4.923 0.61 -0.353 -0.653
資本支出 -4.923 -0.031 -0.353 -0.653
融資活動産生的現金 2.472 462.881 15.357 0.001
股票的發行（報廢），淨額 2.753 473.235 9.44 0.001
債務的發行（退還），淨額 -0.281 0 5.917 0
現金淨變化 -70.552 425.202 0.755 -13.842
Cash Taxes Paid 0.274 0.047
已付現金利息 0.011 0.427
其他投資現金流量項目，總計 0.641
融資現金流項目 -10.354
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -24.533 -83.463 -55.025 -30.459 -14.185
Cash From Operating Activities -20.674 -68.101 -50.613 -25.757 -5.135
Cash From Operating Activities 0.058 0.051 0.017 0.011 0.005
Non-Cash Items 5.926 19.338 8.688 4.241 1.858
Cash Interest Paid 0 0.011 0.007 0.003 0
Changes in Working Capital -2.125 -4.027 -4.293 0.45 7.187
Cash From Investing Activities -183.921 -4.923 -0.405 -0.007 -0.007
Capital Expenditures -0.589 -4.923 -0.405 -0.007 -0.007
Cash From Financing Activities 0.08 2.472 1.948 1.509 0.778
Issuance (Retirement) of Stock, Net 0.185 2.753 2.125 1.582 0.778
Net Change in Cash -204.515 -70.552 -49.07 -24.255 -4.364
Cash Taxes Paid 0 0.274 0.274 0.274
Financing Cash Flow Items 0 0
Issuance (Retirement) of Debt, Net -0.105 -0.281 -0.177 -0.073
Other Investing Cash Flow Items, Total -183.332 0
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
VenBio Partners LLC Private Equity 23.8003 9699925 0 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 14.9987 6112789 1482504 2022-12-31 LOW
Lightstone Ventures, L.P. Investment Advisor 11.1076 4526963 -194027 2022-03-31 LOW
Vivo Capital, LLC Venture Capital 10.3546 4220048 0 2022-12-31 MED
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 7.0445 2871000 0 2022-12-31 LOW
Logos Global Management LLC Investment Advisor 5.7651 2349600 -621752 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.7051 1510050 40991 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.4941 1424043 14289 2022-12-31 LOW
Eventide Asset Management, LLC Investment Advisor 2.2132 902000 0 2022-12-31 MED
Cormorant Asset Management, LP Hedge Fund 1.5018 612079 -100000 2022-12-31 MED
Redmile Group, LLC Investment Advisor/Hedge Fund 1.4905 607470 -144627 2022-12-31 LOW
Pons (Jaume) Individual Investor 1.3244 539746 -3232 2022-12-29 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.2268 500000 0 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 1.171 477236 90049 2022-12-31 MED
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 1.1386 464029 -685 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0117 412309 18988 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.9656 393550 8987 2022-12-31 LOW
DWS Investments UK Limited Investment Advisor 0.84 342355 142 2022-12-31 MED
Pier Capital, LLC Investment Advisor 0.667 271848 -769 2022-12-31 MED
Randolph (Sophia) Individual Investor 0.6631 270253 44857 2022-12-29 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

收入報表

  • Annual
  • Quarterly

人們也觀看

BTC/USD

27,498.20 Price
-0.550% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

Gold

1,978.85 Price
-0.760% 1D Chg, %
多頭倉位隔夜費用 -0.0179%
空頭倉位隔夜費用 0.0097%
隔夜費時間 21:00 (UTC)
價差 0.30

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多頭倉位隔夜費用 -0.0194%
空頭倉位隔夜費用 -0.0025%
隔夜費時間 21:00 (UTC)
價差 0.03

US100

12,798.80 Price
+0.420% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 3.0

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易